Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 1:34 AM
NCT ID:
NCT06977594
Eligibility Criteria:
Inclusion Criteria:
* Patients receiving paclitaxel and carboplatin chemotherapy for gynecologic malignancies.
* Patients with no prior history of hypersensitivity reactions to paclitaxel or carboplatin.
* Patients who are able to read and voluntarily provide written informed consent.
* Aged 19 years or older.
Exclusion Criteria:
* Patients who do not wish to participate in this study voluntarily.
* Patients who, in the opinion of the investigator, are unsuitable for participation in this clinical trial.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
19 Years
Study:
NCT06977594
Study Brief:
Protocol Section:
NCT06977594